Patents by Inventor Guy Mazue

Guy Mazue has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Extracellular form of the human fibroblast growth factor receptor
    Patent number: 5288855
    Abstract: The present invention provides a polypeptide which is capable of binding specifically human basic fibroblast growth factor and human acidic fibroblast growth factor, a DNA sequence which encodes the polypeptide of the invention and a vector which incorporates a DNA sequence of the invention and which is capable, when provided in a transformed host, of expressing the polypeptide of the invention encoded by the DNA sequence. A host transformed with such a vector forms part of the invention also.
    Type: Grant
    Filed: December 28, 1992
    Date of Patent: February 22, 1994
    Assignee: Farmitalia Carlo Erba
    Inventors: Laura Bergonzoni, Guy Mazue, Antonella Isacchi, Romeo Roncucci, Paolo Sarmientos
  • Synergistic composition comprising a fibroblast growth factor and a sulfated polysaccharide, for use as antiviral agent
    Patent number: 5288704
    Abstract: A pharmaceutcial composition is provided for use in the prevention or treatment of viral infections caused by enveloped viruses. The composition comprises a fibroblast growth factor, a sulfated polysaccharide with antiviral activity, and one or more pharmaceutically acceptable carriers. The fibroblast growth factor may be a basic fibroblast growth factor or an analogue thereof, and the polysaccharide may be a carrageenan, heparin, dextran sulfate, pentosan polysulfate or a sulfated polysaccharides produced by marine algae belonging to the class of Rhodophyceae.
    Type: Grant
    Filed: January 31, 1992
    Date of Patent: February 22, 1994
    Assignee: Farmitalia Carlo Erba S.R.L.
    Inventors: Domenico Ungheri, Luisa Garofano, Carlo Battistini, Paolo Carminati, Guy Mazue
  • Hydrochlorides of chlorides of 2-aminoalkyl-9-hydroxy-ellipticinium derivatives and pharmaceutical compositions containing them
    Patent number: 4897398
    Abstract: The invention relates to the 2-aminoalkyl-9-hydroxyellipticinium chloride hydrochloride of formula: ##STR1## in which Z represents hydrogen or a lower alkyl group, Alk represents a lower alkylene group and Am represents a di(lower alkyl)amino, pyrrolidino or piperidino group.These compounds are useful as antitumour agents.
    Type: Grant
    Filed: June 24, 1986
    Date of Patent: January 30, 1990
    Assignees: Sanofi, Centre National de la Recherche Scientifique (C.N.R.S.)
    Inventors: Pierre Gros, Emilio Crisafulli, Guy Mazue